Clarice Montecalvo in Dayton, Ohio

Home Ohio Dayton

Clarice Montecalvo has Family Practice as her primary medical specialty. Their primary office is: 30 E Apple St in Dayton, Ohio. There is an additional office location, for a total of two, for Clarice Montecalvo that can be viewed further down.

They're a part of the: Mvhe Inc medical group which has around 353 members. You can call their office at 937-208-8394 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Wright State University Boonshoft School Of Medicine and graduated in 2018 (around 6 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Clarice M Montecalvo Office Phone and Directions

Clarice Montecalvo
Mvhe Inc
30 E Apple St
Dayton, Ohio 45409
937-208-8394

Patient Ratings
Please rate your experience with Clarice Montecalvo below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 937-208-8394

Enter a starting address:

Healthcare Info for Clarice Montecalvo

Medical School: Wright State University Boonshoft School Of Medicine
Graduation Year: 2018
The Primary Medical Specialty for Clarice Montecalvo is listed as: Family Practice
Approximate Years of Experience: 6
PAC (PECOS ID)#: 8628325222
NPI #: 1457840068
NPI Created On: 05/09/2018
NPI Last Updated Listed as: 05/04/2022
Primary Taxonomy Code: 207Q00000X
License Number:
35.143261
Listed Gender: Female

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $100

Number of Payments:: 1

Form of Payment: In-kind items and services

Context of payment:: ;G2720914;AHM;13215351

Record ID:: 848243211

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: HIV

Name of Drug #1: Descovy

Open Associated Drug #1: 61958-2002-1